[Artificial Intelligence and teleradiology in cardiovascular imaging by CT-Scan and MRI].

Intelligence artificielle et téléradiologie en imagerie cardiaque en coupe.
Artificial Intelligence Calcium score Cardiac CT-Scan Cardiac MRI Cardiovascular prevention Cardiovascular screening Coronaropathie Coronary CT-Scan Coronary artery disease Coroscanner Dépistage cardiovasculaire IRM cardiaque Intelligence artificielle Ischémie myocardique Maladie coronaire Myocardial ischemia Prévention cardiovasculaire Scanner cardiaque Score calcique Teleradiology Téléradiologie

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 23 07 2021
accepted: 01 08 2021
pubmed: 15 9 2021
medline: 15 12 2021
entrez: 14 9 2021
Statut: ppublish

Résumé

Cardiac CT-Scan and cardiac magnetic resonance imaging (MRI) are two booming cardiac imaging modalities especially in chest pain screening for CT-Scan and in surveillance of patients with known coronary artery disease for MRI. Artificial Intelligence is already of great help in radiologic diagnosis and its use should widen in the next few years. Teleradiology allows remote interpretation of all radiology exams and should develop in cardiac imaging. Expert radiology diagnosis centers should develop gathering cardiologists and radiologists with great experience in the field of cardiac imaging interpretation. Peripheral acquisition radiology centers would be disseminated all across the country without a need for a local expert and would send their images to the expert center for interpretation. The expert center would be the middle of this spider web, sending back the report and the selected images to the peripheral center, allowing optimal care for all patients nationwide. Artificial Intelligence would be a major asset of these expert centers, improving through the years. This operating mode would allow the onset of systematic screening for coronary artery disease in the global population and the surveillance of known coronary artery disease treated patients.

Identifiants

pubmed: 34517978
pii: S0003-3928(21)00090-1
doi: 10.1016/j.ancard.2021.08.001
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

339-347

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Adrien Pasteur-Rousseau (A)

Clinique Turin : 9 rue de Turin, 75008, PARIS; Clinique du Parc Monceau : 21 rue de Chazelles, 75017 PARIS; Clinique Floréal : 40 rue Floréal, 93 Bagnolet. Electronic address: adrien.pasteur@gmail.com.

Jean-François Paul (JF)

Institut Mutualiste Montsouris : 42 Boulevard Jourdan, 75014 Paris. Electronic address: dr.jfpaul@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH